Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HGHXE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
MHB-088C
|
|||||
| Synonyms |
MHB-088C; MHB 088C; MHB088C
Click to Show/Hide
|
|||||
| Organization |
Minghui Pharmaceutical (Hangzhou) Co., Ltd.
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
CD276 antigen (CD276)
|
Antigen Info | ||||
| Payload Name |
DNA topoisomerase I inhibitor
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
